Tutogen Medical, Inc. to Present at First Albany Capital's 2nd Annual Orthopedics Conference
February 07 2007 - 7:00AM
PR Newswire (US)
ALACHUA, Fla., Feb. 7 /PRNewswire-FirstCall/ -- Tutogen Medical,
Inc. (AMEX:TTG), a leading manufacturer of sterile biological
implant products made from human (allograft) and animal (xenograft)
tissue, announced today that Guy Mayer, President and Chief
Executive Officer, will be presenting at First Albany Capital's 2nd
Annual Orthopedics Conference on February 13, 2007 at 2:10 p.m.
Pacific time, followed by a breakout session at 2:30 p.m. The
conference is being held at the Marina Village Conference Center,
1936 Quivira Way, San Diego, California. Investors attending the
First Albany conference or the American Association of Orthopaedic
Surgeons (AAOS) conference, also being held in San Diego, should
contact Joe Diaz of Lytham Partners at 602-889-9700 for additional
information. About Tutogen Medical, Inc. Tutogen Medical, Inc.
manufactures sterile biological implant products made from human
(allograft) and animal (xenograft) tissue. Tutogen utilizes its
Tutoplast Process(R) of tissue preservation and viral inactivation
to manufacture and deliver sterile bio-implants used in
spinal/trauma, urology, dental, ophthalmology, and general surgery
procedures. The Company's Tutoplast(R) products are sold and
distributed worldwide by Zimmer Spine and Zimmer Dental,
subsidiaries of Zimmer Holdings, Inc., Davol Inc. subsidiary of
C.R. Bard Inc., the Mentor Corporation (Mentor), Coloplast Corp.,
IOP, Inc. and through independent distributors internationally. For
more information, visit the Company's Web site at
http://www.tutogen.com/. Forward-Looking Statement Disclaimer: This
press release contains "forward-looking statements" within the
meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements typically are identified by use of terms
such as "may," "will," "should," "plan," "expect," "anticipate,"
"estimate," and similar words, although some forward-looking
statements are expressed differently. These statements include, but
are not limited to, statements made by the Company's Chief
Executive Officer concerning the Company's recent financial
performance and trends of quarterly revenue increases, progress
toward profitability, the potential for growth in sales and
continued market acceptance of the Company's hernia repair and
cervical spacer products, potential growth in the Company's dental
and international markets, and management's excitement about the
Company's future opportunities. Forward-looking statements are
based on management's current expectations and are subject to
certain risks and uncertainties that could cause actual results to
differ materially from those set forth or implied by
forward-looking statements. These and other risks are identified in
the Company's filings with the Securities and Exchange Commission,
including the Company's Annual Report on Form 10-K for the fiscal
year ended September 30, 2005, as amended. All information in this
press release is as of the date hereof, and the Company undertakes
no duty to update this information unless required by law.
Contacts: L. Robert Johnston, Jr. Lytham Partners, LLC Chief
Financial Officer Joe Diaz Tutogen Medical, Inc. Joe Dorame
386-462-0402 Robert Blum 602-889-9700 DATASOURCE: Tutogen Medical,
Inc. CONTACT: L. Robert Johnston, Jr., Chief Financial Officer of
Tutogen Medical, Inc., +1-386-462-0402, ; or Joe Diaz, or Joe
Dorame, or Robert Blum, all of Lytham Partners, LLC,
+1-602-889-9700, for Tutogen Medical, Inc. Web site:
http://www.tutogen.com/
Copyright
Tutogen Medical (AMEX:TTG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Tutogen Medical (AMEX:TTG)
Historical Stock Chart
From Jul 2023 to Jul 2024